For the next 5 year cycle of the Cancer Center Support Grant, the Kimmel Cancer Center is requesting approximately $400,000 per year in Developmental Funds. These funds are a critical source of flexible funding for the KCC, and provide a vital source of support for recruitment of new faculty and for pilot project funding. For the next cycle, all the funds requested will be utilized only for those purposes. Center-wide recruitment needs have been identified in four areas: Structural Biology, Radiation Research and Translational Biology, Genito-Urinary Cancer, and Cancer Genetics. Developmental Funds will enable recruitments in these areas, which will not only strengthen specific areas of need, but also enhance intra- and inter-programmatic collaborations. The pilot project funding initiative established in the previous cycle also will be continued with the support of Developmental Funds. During the previous cycle, Developmental Funds were used to support: 1) faculty recruitment, 2) establishment of new shared resources, and 3) support for pilot projects aimed at the submission of program project applications. The results of this funding have proven the expenditure of Developmental Funds to be very beneficial. New faculty recruited with and supported by Developmental Funds have been highly successful in establishing their laboratories, acquiring external, peer-reviewed funding, and starting to publish the results of their studies. Developmental Funds also enabled the establishment of two new shared resources (Microarray, and Proteomics and Mass Spectrometry) which have proven so invaluable to cancer center researchers that they will be transformed into full KCC shared resources in the next cycle. Numerous publications in top peer-reviewed journals have already resulted from the activities of these new shared resources. Developmental Funds also facilitated the recruitment of outstanding new Directors for both of these shared resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-13
Application #
8378868
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
13
Fiscal Year
2012
Total Cost
$342,832
Indirect Cost
$120,123
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Mikkilineni, Lekha; Whitaker-Menezes, Diana; Domingo-Vidal, Marina et al. (2017) Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Semin Oncol 44:218-225
Wirblich, Christoph; Coleman, Christopher M; Kurup, Drishya et al. (2017) One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. J Virol 91:
Weinberg, David S; Lin, Jieru E; Foster, Nathan R et al. (2017) Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer Prev Res (Phila) 10:345-354
Monti, Daniel; Sotgia, Federica; Whitaker-Menezes, Diana et al. (2017) Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Semin Oncol 44:226-232
Curry, Joseph; Johnson, Jennifer; Tassone, Patrick et al. (2017) Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. Laryngoscope 127:1808-1815
Mitra, Ramkrishna; Chen, Xi; Greenawalt, Evan J et al. (2017) Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun 8:1604
Paolillo, Carmela; Mu, Zhaomei; Rossi, Giovanna et al. (2017) Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells. Clin Cancer Res 23:6086-6093
Overmiller, Andrew M; Pierluissi, Jennifer A; Wermuth, Peter J et al. (2017) Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. FASEB J 31:3412-3424
Cheng, Hanyin; Chua, Vivian; Liao, Connie et al. (2017) Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma. Mol Cancer Ther 16:516-528
Jiang, Wei; Dulaimi, Essel; Devarajan, Karthik et al. (2017) Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget 8:37423-37434

Showing the most recent 10 out of 777 publications